XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Collaboration Agreements, License Agreement and Revenues - Deferred Revenue - Additional Information (Detail) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Product Revenue, Net [Member] | Beijing Falikang Pharmaceutical Co Ltd    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Reductions to gross accounts receivable $ 6,500 $ 13,400
AstraZeneca Agreements [Member]    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Deferred revenue 170,514 $ 171,516
AstraZeneca Agreements [Member] | China [Member]    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Deferred revenue $ 14,900